Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
Featured post
Quantitative Strategies for Rare Disease Clinical Trials
Rare disease studies have specific challenges, such as small populations, limited prior knowledge on a disease, and difficulty in defining appropriate endpoints. Effective clinical development strategy for rare diseases requires agility to adapt to accumulating learning.
Here, we provide a brief overview on the construction of endpoints, adaptive and seamless clinical trial designs, Bayesian approaches, and the use of natural history studies in the development of rare disease studies.
Clear Filters
Filter by
February 14, 2023
The U.S. FDA has recently provided specific guidance[i] on the design and conduct of trials incorporating an external...
Read article